Skip to main content

Burn Wound Infection

  • Chapter
  • First Online:
Essential Burn Care for Non-Burn Specialists

Abstract

Burn wound infections are common and early complications in patients with burn injuries with the greatest risk factors being higher total body surface area burns and delayed excision of the eschar. Clinical suspicion of wound infection is based on changes to the burn wound such as edema, erythema, pain, and purulence. The gold standard of diagnosis is culture and histology. Early infections are most commonly caused by gram-positive organisms, such as Staphylococcus aureus. With longer hospital stays, infections are more likely to be caused by gram-negative organisms such as Pseudomonas aeruginosa, which can harbor antibiotic resistance. Surgical debridement is the fundamental treatment of burn wound infection in combination with topical antimicrobials such as silver-based therapies and systemic antibiotics that are targeted based on the patient and/or local antibiogram susceptibilities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19(2):403–34.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Alp E, Coruh A, Gunay GK, Yontar Y, Doganay M. Risk factors for nosocomial infection and mortality in burn patients: 10 years of experience at a university hospital. J Burn Care Res. 2012;33(3):379–85.

    Article  PubMed  Google Scholar 

  3. van Duin D, Strassle PD, DiBiase LM, Lachiewicz AM, Rutala WA, Eitas T, et al. Timeline of health care-associated infections and pathogens after burn injuries. Am J Infect Control. 2016;44(12):1511–6.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Blyth DM. Burns. In: Mandell Douglas and Bennett's principles and practice of infectious diseases, 9th ed. [Internet]. Elsevier; 2019.

    Google Scholar 

  5. Fitzwater J, Purdue GF, Hunt JL, O'Keefe GE. The risk factors and time course of sepsis and organ dysfunction after burn trauma. J Trauma. 2003;54(5):959–66.

    Article  PubMed  Google Scholar 

  6. Gamelli RL, He LK, Liu H. Marrow granulocyte-macrophage progenitor cell response to burn injury as modified by endotoxin and indomethacin. J Trauma. 1994;37(3):339–46.

    Article  CAS  PubMed  Google Scholar 

  7. Calum H, Moser C, Jensen P, Christophersen L, Maling DS, van Gennip M, et al. Thermal injury induces impaired function in polymorphonuclear neutrophil granulocytes and reduced control of burn wound infection. Clin Exp Immunol. 2009;156(1):102–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock (Augusta, GA). 1999;11(3):153–9.

    Article  CAS  PubMed  Google Scholar 

  9. Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis. 2003;37(4):543–50.

    Article  PubMed  Google Scholar 

  10. Herndon DN, Barrow RE, Rutan RL, Rutan TC, Desai MH, Abston S. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg. 1989;209(5):547–52; discussion 52-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lloyd JR, Hight DW. Early laminar excision: improved control of burn wound sepsis by partial dermatome debridement. J Pediatr Surg. 1978;13(6d):698–706.

    Article  CAS  PubMed  Google Scholar 

  12. Jones I, Currie L, Martin R. A guide to biological skin substitutes. Br J Plast Surg. 2002;55(3):185–93.

    Article  CAS  PubMed  Google Scholar 

  13. Atiyeh BS, Hayek SN, Gunn SW. New technologies for burn wound closure and healing—review of the literature. Burns 2005;31(8):944-956.

    Google Scholar 

  14. Lindberg RB, Moncrief JA, Switzer WE, Order SE, Mills W Jr. The successful control of burn wound sepsis. J Trauma. 1965;5(5):601–16.

    Article  CAS  PubMed  Google Scholar 

  15. Fox CL Jr. Silver sulfadiazine—a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg (Chicago, Ill : 1960). 1968;96(2):184–8.

    Article  Google Scholar 

  16. Greenhalgh DG, Saffle JR, Holmes JH, Gamelli RL, Palmieri TL, Horton JW, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007;28(6):776–90.

    Article  PubMed  Google Scholar 

  17. Mitchell V, Galizia JP, Fournier L. Precise diagnosis of infection in burn wound biopsy specimens. Combination of histologic technique, acridine orange staining, and culture. The. J Burn Care Rehabil. 1989;10(3):195–202.

    Article  CAS  PubMed  Google Scholar 

  18. McManus AT, Kim SH, McManus WF, Mason AD Jr, Pruitt BA Jr. Comparison of quantitative microbiology and histopathology in divided burn-wound biopsy specimens. Arch Surg (Chicago, Ill : 1960). 1987;122(1):74–6.

    Article  CAS  Google Scholar 

  19. Loebl EC, Marvin JA, Heck EL, Curreri PW, Baxter CR. The use of quantitative biopsy cultures in bacteriologic monitoring of burn patients. J Surg Res. 1974;16(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  20. Kwei J, Halstead FD, Dretzke J, Oppenheim BA, Moiemen NS. Protocol for a systematic review of quantitative burn wound microbiology in the management of burns patients. Syst Rev. 2015;4:150.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Halstead FD, Lee KC, Kwei J, Dretzke J, Oppenheim BA, Moiemen NS. A systematic review of quantitative burn wound microbiology in the management of burns patients. Burns. 2018;44(1):39–56.

    Article  PubMed  Google Scholar 

  22. Levine NS, Lindberg RB, Mason AD Jr, Pruitt BA Jr. The quantitative swab culture and smear: a quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma. 1976;16(2):89–94.

    Article  CAS  PubMed  Google Scholar 

  23. Winkler M, Erbs G, König W, Müller FE. Comparison of 4 methods of bacterial count determination in burn wounds. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology. 1987;265(1–2):82–98.

    Article  CAS  PubMed  Google Scholar 

  24. Steer JA, Papini RP, Wilson AP, McGrouther DA, Parkhouse N. Quantitative microbiology in the management of burn patients. I. Correlation between quantitative and qualitative burn wound biopsy culture and surface alginate swab culture. Burns. 1996;22(3):173–6.

    Article  CAS  PubMed  Google Scholar 

  25. Luo G, Tan J, Peng Y, Wu J, Huang Y, Peng D, et al. Guideline for diagnosis, prophylaxis and treatment of invasive fungal infection post burn injury in China 2013. Burns Trauma. 2014;2(2):45–52.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Horvath EE, Murray CK, Vaughan GM, Chung KK, Hospenthal DR, Wade CE, et al. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg. 2007;245(6):978–85.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Blyth DM, Chung KK, Cancio LC, King BT, Murray CK. Clinical utility of fungal screening assays in adults with severe burns. Burns. 2013;39(3):413–9.

    Article  PubMed  Google Scholar 

  28. Legrand M, Gits-Muselli M, Boutin L, Garcia-Hermoso D, Maurel V, Soussi S, et al. Detection of circulating mucorales DNA in critically ill burn patients: preliminary report of a screening strategy for early diagnosis and treatment. Clin Infect Dis. 2016;63(10):1312–7.

    Article  CAS  PubMed  Google Scholar 

  29. Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns. 2004;30(4):357–61.

    Article  PubMed  Google Scholar 

  30. Manson WL, Pernot PC, Fidler V, Sauer EW, Klasen HJ. Colonization of burns and the duration of hospital stay of severely burned patients. J Hosp Infect. 1992;22(1):55–63.

    Article  CAS  PubMed  Google Scholar 

  31. Murray PM, Finegold SM. Anaerobes in burn-wound infections. Rev Infect Dis. 1984;6(Suppl 1):S184–6.

    Article  PubMed  Google Scholar 

  32. Dokter J, Brusselaers N, Hendriks WD, Boxma H. Bacteriological cultures on admission of the burn patient: to do or not to do, that's the question. Burns. 2016;42(2):421–7.

    Article  CAS  PubMed  Google Scholar 

  33. Park HS, Pham C, Paul E, Padiglione A, Lo C, Cleland H. Early pathogenic colonisers of acute burn wounds: a retrospective review. Burns. 2017;43(8):1757–65.

    Article  PubMed  Google Scholar 

  34. Lesseva M, Girgitzova BP, Bojadjiev C. Beta-haemolytic streptococcal infections in burned patients. Burns. 1994;20(5):422–5.

    Article  CAS  PubMed  Google Scholar 

  35. Sheridan RL, Weber JM, Pasternack MS, Tompkins RG. Antibiotic prophylaxis for group A streptococcal burn wound infection is not necessary. J Trauma. 2001;51(2):352–5.

    Article  CAS  PubMed  Google Scholar 

  36. Pangli H, Papp A. The relation between positive screening results and MRSA infections in burn patients. Burns. 2019;45(7):1585–92.

    Article  PubMed  Google Scholar 

  37. Altoparlak U, Erol S, Akcay MN, Celebi F, Kadanali A. The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns. 2004;30(7):660–4.

    Article  PubMed  Google Scholar 

  38. Keen EF 3rd, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, et al. Prevalence of multidrug-resistant organisms recovered at a military burn center. Burns. 2010;36(6):819–25.

    Article  PubMed  Google Scholar 

  39. Azzopardi EA, Azzopardi E, Camilleri L, Villapalos J, Boyce DE, Dziewulski P, et al. Gram negative wound infection in hospitalised adult burn patients—systematic review and metanalysis. PloS One. 2014;9(4):e95042.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–77.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Maurel V, Denis B, Camby M, Jeanne M, Cornesse A, Glavnik B, et al. Outcome and characteristics of invasive fungal infections in critically ill burn patients: A multicenter retrospective study. Mycoses. 2020;63(6):535–42.

    Article  PubMed  Google Scholar 

  42. Cochran A, Morris SE, Edelman LS, Saffle JR. Systemic Candida infection in burn patients: a case-control study of management patterns and outcomes. Surg Infect (Larchmt). 2002;3(4):367–74.

    Article  PubMed  Google Scholar 

  43. Ballard J, Edelman L, Saffle J, Sheridan R, Kagan R, Bracco D, et al. Positive fungal cultures in burn patients: a multicenter review. J Burn Care Res. 2008;29(1):213–21.

    Article  PubMed  Google Scholar 

  44. Devauchelle P, Jeanne M, Fréalle E. Mucormycosis in burn patients. J Fungi (Basel, Switzerland). 2019;5(1)

    Google Scholar 

  45. Kiley JL, Chung KK, Blyth DM. Viral infections in burns. Surg Infect (Larchmt). 2020;

    Google Scholar 

  46. Dai T, Huang YY, Sharma SK, Hashmi JT, Kurup DB, Hamblin MR. Topical antimicrobials for burn wound infections. Recent Pat Antiinfect Drug Discov. 2010;5(2):124–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Lansdown AB. Silver. I: its antibacterial properties and mechanism of action. J Wound Care. 2002;11(4):125–30.

    Article  CAS  PubMed  Google Scholar 

  48. Stefanides MM Sr, Copeland CE, Kominos SD, Yee RB. In vitro penetration of topical antiseptics through eschar of burn patients. Ann Surg. 1976;183(4):358–64.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev. 2010;(3):Cd006478.

    Google Scholar 

  50. Wasiak J, Cleland H, Campbell F, Spinks A. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2013;2013(3):Cd002106.

    PubMed  PubMed Central  Google Scholar 

  51. Cooper ML, Boyce ST, Hansbrough JF, Foreman TJ, Frank DH. Cytotoxicity to cultured human keratinocytes of topical antimicrobial agents. J Surg Res. 1990;48(3):190–5.

    Article  CAS  PubMed  Google Scholar 

  52. Cartotto R. Topical antimicrobial agents for pediatric burns. Burns Trauma. 2017;5:33.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Burke JF, Bondoc CC, Morris PJ. Metabolic effects of topical silver nitrate therapy in burns covering more than fifteen percent of the body surface. Ann N Y Acad Sci. 1968;150(3):674–80.

    Article  CAS  PubMed  Google Scholar 

  54. Glasser JS, Guymon CH, Mende K, Wolf SE, Hospenthal DR, Murray CK. Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients. Burns. 2010;36(8):1172–84.

    Article  PubMed  Google Scholar 

  55. White MG, Asch MJ. Acid-base effects of topical mafenide acetate in the burned patient. N Engl J Med. 1971;284(23):1281–6.

    Article  CAS  PubMed  Google Scholar 

  56. Rode H, Hanslo D, de Wet PM, Millar AJ, Cywes S. Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection. Antimicrob Agents Chemother. 1989;33(8):1358–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Strock LL, Lee MM, Rutan RL, Desai MH, Robson MC, Herndon DN, et al. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci. J Burn Care Rehabil. 1990;11(5):454–9.

    Article  CAS  PubMed  Google Scholar 

  58. Jaspers ME, Breederveld RS, Tuinebreijer WE, Diederen BM. The evaluation of nasal mupirocin to prevent Staphylococcus aureus burn wound colonization in routine clinical practice. Burns. 2014;40(8):1570–4.

    Article  CAS  PubMed  Google Scholar 

  59. Barsoumian A, Sanchez CJ, Mende K, Tully CC, Beckius ML, Akers KS, et al. In vitro toxicity and activity of Dakin's solution, mafenide acetate, and amphotericin B on filamentous fungi and human cells. J Orthop Trauma. 2013;27(8):428–36.

    Article  PubMed  Google Scholar 

  60. Barret JP, Ramzy PI, Heggers JP, Villareal C, Herndon DN, Desai MH. Topical nystatin powder in severe burns: a new treatment for angioinvasive fungal infections refractory to other topical and systemic agents. Burns. 1999;25(6):505–8.

    Article  CAS  PubMed  Google Scholar 

  61. Ergün O, Celik A, Ergün G, Ozok G. Prophylactic antibiotic use in pediatric burn units. Eur J Pediatr Surg = Zeitschrift fur Kinderchirurgie. 2004;14(6):422–6.

    Article  PubMed  Google Scholar 

  62. Kiser TH, Hoody DW, Obritsch MD, Wegzyn CO, Bauling PC, Fish DN. Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury. Antimicrob Agents Chemother. 2006;50(6):1937–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Conil JM, Georges B, Breden A, Segonds C, Lavit M, Seguin T, et al. Increased amikacin dosage requirements in burn patients receiving a once-daily regimen. Int J Antimicrob Agents. 2006;28(3):226–30.

    Article  CAS  PubMed  Google Scholar 

  64. Stone HH, Cuzzell JZ, Kolb LD, Moskowitz MS, McGowan JE Jr. Aspergillus infection of the burn wound. J Trauma. 1979;19(10):765–7.

    Article  CAS  PubMed  Google Scholar 

  65. Rodriguez CJ, Tribble DR, Murray CK, Jessie EM, Khan M et al. Invasive fungal infection in war wounds. Joint Trauma Service Clinical Practice Guidelines; 2016.

    Google Scholar 

  66. Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, van Duin D. Bacterial infections after burn injuries: impact of multidrug resistance. Clin Infect Dis. 2017;65(12):2130–6.

    Article  PubMed  PubMed Central  Google Scholar 

  67. McManus AT, Mason AD Jr, McManus WF, Pruitt BA Jr. A decade of reduced gram-negative infections and mortality associated with improved isolation of burned patients. Arch Surg (Chicago, Ill : 1960, 1994;129(12):1306–9.

    Google Scholar 

  68. Mayhall CG, Lamb VA, Gayle WE Jr, Haynes BW Jr. Enterobacter cloacae septicemia in a burn center: epidemiology and control of an outbreak. J Infect Dis. 1979;139(2):166–71.

    Article  CAS  PubMed  Google Scholar 

  69. Embil JM, McLeod JA, Al-Barrak AM, Thompson GM, Aoki FY, Witwicki EJ, et al. An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipment. Burns. 2001;27(7):681–8.

    Article  CAS  PubMed  Google Scholar 

  70. Davison PG, Loiselle FB, Nickerson D. Survey on current hydrotherapy use among North American burn centers. J Burn Care Res. 2010;31(3):393–9.

    Article  PubMed  Google Scholar 

  71. Popp JA, Layon AJ, Nappo R, Richards WT, Mozingo DW. Hospital-acquired infections and thermally injured patients: chlorhexidine gluconate baths work. Am J Infect Control. 2014;42(2):129–32.

    Article  CAS  PubMed  Google Scholar 

  72. Thompson JT, Meredith JW, Molnar JA. The effect of burn nursing units on burn wound infections. J Burn Care Rehabil. 2002;23(4):281–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Marcus, J.E., Chung, K.K., Blyth, D.M. (2023). Burn Wound Infection. In: Lee, J.O. (eds) Essential Burn Care for Non-Burn Specialists. Springer, Cham. https://doi.org/10.1007/978-3-031-28898-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-28898-2_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-28897-5

  • Online ISBN: 978-3-031-28898-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics